Sight Sciences
Yahoo Finance • last year
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Sight Sciences, Inc. (NASDAQ: SGHT) and Encourages Investors to Contact the Firm
PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Sight Sciences, Inc. (NASDAQ: SGHT) (“Sight Sciences”) on behalf of the company’s investors. Since January 2023, shares of Sight Sciences... Full story
Yahoo Finance • last year
Sight Sciences Reports Third Quarter 2023 Financial Results and Withdraws Guidance for Full Year 2023
MENLO PARK, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing innovative technology intended to tran... Full story
Yahoo Finance • last year
INVESTOR ALERT: Abbott Cooper PLLC Announces Investigation into Sight Sciences, Inc.; Urges Sight Sciences Stockholders to Contact Abbott Cooper Regarding Their Legal Rights
STAMFORD, Conn., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Abbott Cooper PLLC is investigating Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”) on behalf of the Company’s investors. The investigation seeks to determine wh... Full story
Yahoo Finance • last year
Sight Sciences to Report Third Quarter 2023 Financial Results on November 7, 2023
MENLO PARK, Calif., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on developing and commercializing innovative technology intended to tra... Full story
Yahoo Finance • last year
Sight Sciences to Host SAHARA 6 Month RCT Results Reception at the American Academy of Ophthalmology 2023
MENLO PARK, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on developing and commercializing innovative technology intended to tra... Full story
Yahoo Finance • last year
Sight Sciences Announces Presentation of Successful Phase I Results of the SAHARA Randomized Controlled Clinical Trial Comparing TearCare® to Restasis® for the Treatment of Dry Eye Disease at the American Academy of Optometry Annual Meeting
MENLO PARK, Calif., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on developing and commercializing innovative technology intended to tra... Full story
Yahoo Finance • last year
Sight Sciences Announces New, Large-Scale MIGS Data from 41st Congress of ESCRS Demonstrating TCOR™ Using OMNI® Surgical System Technology is Effective at Lowering Both IOP and IOP Reducing Medications at 2 Years in Patients with Glaucoma
MENLO PARK, Calif., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences”), an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and im... Full story
Yahoo Finance • last year
Investigation of Sight Sciences, Inc. (SGHT) Announced by Holzer & Holzer, LLC
ATLANTA, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Sight Sciences, Inc. (“Sight Sciences” or “the Company”) (NASDAQ: SGHT) complied with federal securities laws. On September 11, 2023, Sight Science... Full story
Yahoo Finance • last year
Sight Sciences to Present at the Upcoming Morgan Stanley 21st Annual Global Healthcare Conference
MENLO PARK, Calif., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on developing and commercializing innovative technology intended to tra... Full story
Yahoo Finance • 2 years ago
Cigna Expands Coverage of Glaucoma Surgical Procedures to Include Canaloplasty and Goniotomy (Trabeculotomy)
Cigna has close to 15 million covered lives Cigna’s Coverage Policy includes procedures enabled with OMNI® Surgical System technology as medically necessary and covered MENLO PARK, Calif., June 21, 2023 (GLOBE NEWSWIRE) -- Sight Scienc... Full story
Yahoo Finance • 2 years ago
Sight Sciences Announces Addition of New Director Catherine Mazzacco
MENLO PARK, Calif., June 09, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on creating innovative solutions intended to transform care and improve... Full story
Yahoo Finance • 2 years ago
Sight Sciences Announces 12-month Results from the First Minimally Invasive Glaucoma Surgery (MIGS) Comparative Analysis of Real-World Data (RWD) from the American Academy of Ophthalmology IRIS® Registry
MENLO PARK, Calif., May 06, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative technology that enables procedures intended to improve patients'... Full story
Yahoo Finance • 2 years ago
Sight Sciences to Report First Quarter 2023 Financial Results on May 4, 2023
MENLO PARK, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, today announced it... Full story
Yahoo Finance • 2 years ago
Sight Sciences to Host Surgical Glaucoma Investor Symposium on Friday, May 5, 2023
MENLO PARK, Calif., April 13, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on creating innovative solutions intended to transform care and impro... Full story
Yahoo Finance • 2 years ago
Sight Sciences Appoints Ali Bauerlein as Chief Financial Officer
MENLO PARK, Calif., April 03, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on creating innovative solutions intended to transform care and improve... Full story
Yahoo Finance • 2 years ago
Sight Sciences Defeats Invalidity Challenges Filed By Alcon and Ivantis In The U.S. Patent Office
MENLO PARK, Calif., March 30, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on creating innovative solutions intended to transform care and improv... Full story
Yahoo Finance • 2 years ago
Sight Sciences Reports Fourth Quarter and Full Year 2022 Financial Results
MENLO PARK, Calif., March 13, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on creating innovative solutions intended to transform care and improv... Full story
Yahoo Finance • 2 years ago
Sight Sciences Launches the Ergo-Series of the OMNI® Surgical System
MENLO PARK, Calif., March 09, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative technology that provides solutions intended to transform care... Full story
Yahoo Finance • 2 years ago
Sight Sciences to Report Fourth Quarter and Full Year 2022 Financial Results on March 13, 2023
MENLO PARK, Calif., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, today announced it... Full story
Yahoo Finance • 2 years ago
Sight Sciences to Present at the Upcoming Citi 2023 Healthcare Services, Medtech, Tools & HCIT Conference
MENLO PARK, Calif., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, today announced pla... Full story
